SCIENTURE HOLDINGS, INC. Convertible Notes Payable
SCIENTURE HOLDINGS, INC. (SCNX) had Convertible Notes Payable of $181.50 thousand as of 2017-12-31, per its 10-K filed 2019-03-22.
Discontinued › Balance Sheet › Liabilities › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2019-03-22
- 2017-12-31: Convertible Notes Payable $181.50K.
- 2017-03-31: Convertible Notes Payable $0.00.
- 2016-12-31: Convertible Notes Payable $10.59K.
- 2016-09-30: Convertible Notes Payable $963.67K.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2017-12-31 | $181.50K 10-K · filed 2019-03-22 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $10.59K 10-Q · filed 2017-05-15 | |
| 2016-09-30 | $963.67K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $943.73K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $191.08K 10-Q · filed 2016-04-20 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-30 | $164.30K 10-K · filed 2016-03-28 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |